Analysis using Western blot revealed that the levels of BAX and Caspase-3 increased while BCL-2 decreased upon treatment with IL-1β, indicating stimulation of NPC apoptosis and progression of IDD. This evidence concerns the gene BCL2 and nasopharyngeal carcinoma.